Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Ingham

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2017
Cell-Cycle Therapeutics Come of AgeMatthew Ingham, Gary K Schwartz
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 17, 2022
Novel Therapeutics in the Treatment of Uterine SarcomaSminu Bose, Gary K Schwartz, Matthew Ingham
Frontiers in Oncology|March 27, 2023
Therapeutic advances in leiomyosarcomaKristine Lacuna, Sminu Bose, Matthew Ingham, et al.
Frontiers in Oncology|November 1, 2023
Editorial: New therapeutics for soft tissue sarcomasMarla Weetall, Mark Rance, Matthew Ingham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2017
Emerging Targeted and Immune-Based Therapies in SarcomaSeth M Pollack, Matthew Ingham, Matthew B Spraker, et al.
Seminars in Oncology|November 13, 2020
Homologous recombination repair deficiency as a therapeutic target in sarcomaJay Oza, Sahil D Doshi, Luke Hao, et al.
JCO Precision Oncology|January 20, 2022
Assay Complementarity to Overcome False-Negative Testing for Microsatellite Instability/Mismatch Repair Deficiency: A Pembrolizumab-Sensitive Intimal SarcomaBrian S Henick, Matthew Ingham, Maryam Shirazi, et al.
JCO Precision Oncology|July 12, 2022
CDK4/6 Inhibition With Anti-PD-1 Checkpoint Blockade Induces Major Response in Aggressive Classic Kaposi Sarcoma After Previous Progression on Anti-PD-1 AloneSminu Bose, Tristan Lee, Shaelyn Choi, et al.
Urology|January 29, 2013
Using preoperative albumin levels as a surrogate marker for outcomes after radical cystectomy for bladder cancerJack W Lambert, Matthew Ingham, Bethany Barone Gibbs, et al.
JCO Precision Oncology|January 7, 2022
Clinical Benefit From Immune Checkpoint Blockade in Sclerosing Epithelioid Fibrosarcoma: A Translocation-Associated SarcomaSahil D Doshi, Jay Oza, Helen Remotti, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2017
Cell-Cycle Therapeutics Come of AgeMatthew Ingham, Gary K Schwartz
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 17, 2022
Novel Therapeutics in the Treatment of Uterine SarcomaSminu Bose, Gary K Schwartz, Matthew Ingham
Frontiers in Oncology|March 27, 2023
Therapeutic advances in leiomyosarcomaKristine Lacuna, Sminu Bose, Matthew Ingham, et al.
Frontiers in Oncology|November 1, 2023
Editorial: New therapeutics for soft tissue sarcomasMarla Weetall, Mark Rance, Matthew Ingham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2017
Emerging Targeted and Immune-Based Therapies in SarcomaSeth M Pollack, Matthew Ingham, Matthew B Spraker, et al.
Seminars in Oncology|November 13, 2020
Homologous recombination repair deficiency as a therapeutic target in sarcomaJay Oza, Sahil D Doshi, Luke Hao, et al.
JCO Precision Oncology|January 20, 2022
Assay Complementarity to Overcome False-Negative Testing for Microsatellite Instability/Mismatch Repair Deficiency: A Pembrolizumab-Sensitive Intimal SarcomaBrian S Henick, Matthew Ingham, Maryam Shirazi, et al.
JCO Precision Oncology|July 12, 2022
CDK4/6 Inhibition With Anti-PD-1 Checkpoint Blockade Induces Major Response in Aggressive Classic Kaposi Sarcoma After Previous Progression on Anti-PD-1 AloneSminu Bose, Tristan Lee, Shaelyn Choi, et al.
Urology|January 29, 2013
Using preoperative albumin levels as a surrogate marker for outcomes after radical cystectomy for bladder cancerJack W Lambert, Matthew Ingham, Bethany Barone Gibbs, et al.
JCO Precision Oncology|January 7, 2022
Clinical Benefit From Immune Checkpoint Blockade in Sclerosing Epithelioid Fibrosarcoma: A Translocation-Associated SarcomaSahil D Doshi, Jay Oza, Helen Remotti, et al.
Pageof 4